(Q44098828)

English

CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 November 2017

CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6. (English)

1 reference

Europe PubMed Central

29 November 2017

0 references

author name string

Y W Francis Lam

1

1 reference

Europe PubMed Central

29 November 2017

Andrea Gaedigk

2

1 reference

Europe PubMed Central

29 November 2017

Larry Ereshefsky

3

1 reference

Europe PubMed Central

29 November 2017

Cara L Alfaro

4

1 reference

Europe PubMed Central

29 November 2017

Joe Simpson

5

1 reference

Europe PubMed Central

29 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

29 November 2017

Pharmacotherapy

1 reference

Europe PubMed Central

29 November 2017

22

1 reference

Europe PubMed Central

29 November 2017

1001-1006

1 reference

Europe PubMed Central

29 November 2017

8

1 reference

Europe PubMed Central

29 November 2017

Elevated serum phenytoin concentrations associated with coadministration of sertraline

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

CYP2D6 inhibition in patients treated with sertraline.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Pharmacokinetics of the newer antidepressants: clinical relevance

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Fluoxetine and norfluoxetine plasma concentrations in major depression: a multicenter study.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.22.12.1001.33603

21 January 2018

Identifiers

10.1592/PHCO.22.12.1001.33603

1 reference

Europe PubMed Central

29 November 2017

1 reference

Europe PubMed Central

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44098828&oldid=2106576275"